Highly Potent and Selective Fluorescent Antagonists of the Human Adenosine A<sub>3</sub> Receptor Based on the 1,2,4-Triazolo[4,3-<i>a</i>]quinoxalin-1-one Scaffold
Andrea J. Vernall(University of Nottingham), Barrie Kellam(University of Nottingham), Stephen J. Hill(University of Nottingham), Leigh A. Stoddart(University of Glasgow), Stephen J. Briddon(University of Nottingham)
Cited by 45
Related Papers
Agonist and Inverse Agonist Actions of β-Blockers at the Human β2-Adrenoceptor Provide Evidence for Agonist-Directed Signaling
|Molecular Pharmacology|2003|187
The p85 Subunit of Phosphatidylinositol 3-Kinase Associates with the Fc Receptor γ-Chain and Linker for Activitor of T Cells (LAT) in Platelets Stimulated by Collagen and Convulxin
|Journal of Biological Chemistry|1998|145
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling
|Trends in Pharmacological Sciences|2011|134
Quantitative analysis of the formation and diffusion of A <sub>1</sub> -adenosine receptor-antagonist complexes in single living cells
|Proceedings of the National Academy of Sciences|2004|117
Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates
|Trends in Pharmacological Sciences|2007|114